Latest Cancer News

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three... Continue Reading

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (05-17-2012)
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading

What's New

An Official Statement from Governor Jodi Rell on “Clinical Trial Initiative Month”

Grant Awarded for Community Education Regarding Clinical Trials
Connecticut Oncology and Hematology is proud to announce that the practice is the recipient of a grant from the Connecticut Clinical Trials Network.

Read More »

Research at Connecticut Oncology

Read More »



Locations

Torrington Location
200 Kennedy Drive
Torrington, CT 06790
860-482-5384
Sharon Location
19 West Main Street
Sharon, CT 06069
860-364-0531